Tag archive for ‘hostile takeover’
Vered Weiss On Sunday, November 9th, 2014

Jim Cramer: Good Thing Allergan Didn’t Buy Salix

Salix Pharmaceuticals was considered as a potential buy by Allergan to ward off a hostile takeover by Valeant Pharmaceuticals and activist investor Bill Ackman. Jim Cramer pointed out on CNBC that it is fortunate More...

Vered Weiss On Wednesday, November 5th, 2014

Judge Implies Whiff of Impropriety about Allergan Hostile Bid, but Won’t Bar Ackman, Valeant, from Voting

–   While federal judge David Carter said Allergan had raised ” serious questions” about the legal implication of Bill Ackman’s Pershing Square and Valeant’s $53 billion takeover More...

Vered Weiss On Monday, October 13th, 2014

Rio Tinto Fleeing Ivan Glasenberg’s Advances, May Find Sanctuary in Freeport

Rio Tinto, desperate to avoid being taken over by Glencore, may buy Freeport McMoRan in a deal that is a “classic defensive move, ” according to Bernstein analyst Paul Gait, as reported by More...

Vered Weiss On Wednesday, October 8th, 2014

Actavis Joins In the Battle for Botox, Valeant Raises Its Bid

–   With the hostile takeover saga of Botox-maker Allergan raging on for months, the situation has become even more complicated, with Actavis jumping with a bid for Allergan, as reported by Reuters. More...

Vered Weiss On Thursday, October 2nd, 2014

Bill Ackman Raises $3 Billion Before Pershing Square’s Euronext Debut

Bill Ackman, manager of Pershing Square, raised $3 billion prior to Pershing Square’s debut on Amsterdam Euronext, scheduled for October 13. The fund will be priced at $25 a share, which gives Pershing More...

Vered Weiss On Wednesday, September 24th, 2014

Allergan Is Dancing as Fast as It Can to Avoid Valeant Takeover with Salix Deal

Allergan, which has received a well-storied hostile takeover bid from Valeant Pharmaceutical, courtesy of hedge fund manager Bill Ackman is making acquisitions to show it can perform well solo. Its next move More...

Vered Weiss On Thursday, September 11th, 2014

John Paulson’s Say Could Be Crucial in Deciding Who Buys Family Dollar

Family Dollar is up for sale. The question is, who is going to buy it? Dollar Tree made an initial bid for the company of $74.50 a share in July, while Dollar General has gotten into the game with a higher More...

Vered Weiss On Monday, September 8th, 2014

Does Bill Ackman Need Botox More Than Botox Needs Ackman?

Looking youthful for his mid-forties, Bill Ackman doesn’t seem to need Botox. So why is he so hot on the trail for Allergan, encouraging the Botox maker to acquiesce to Valeant’s hostile takeover More...

Vered Weiss On Friday, September 5th, 2014

John Paulson Adds Battleground Stock Allergan

Fund manager John Paulson added a new position in controversial stock Allergan, which is the object of a hostile takeover bid by Valeant Pharmaceuticals. The Allergan position now accounts for 4.11% of Paulson’s More...

Vered Weiss On Wednesday, August 20th, 2014

Allergan May Acquire Salix Pharmaceuticals to Ward off Valeant and Bill Ackman

Allergan (AGN), desperately avoiding a hostile takeover bid from Valeant (VRX), which was spurred on by pitbull … er …  hedge fund manager Bill Ackman, has decided that it will get overweight with More...

Wordpress site Developed by Fixing WordPress Problems